NewsBite

The A2 Milk Company

Advertisement
A2 Milk chief executive David Bortolussi.

A2 Milk boss warns of use-by date for Chinese daigou shopping heyday

The changing shopping preferences of Chinese parents and tighter competition is forcing baby formula business A2 Milk to seek out new ways to survive the headwinds.

  • Jessica Yun

Latest

Spilt milk: How Aussie mums and dads got dragged into Bubs’ boardroom fight

This time last year, Bubs Australia was collecting accolades from US President Joe Biden. But a spectacular fallout between the co-founder and her board has sent the business reeling – and left investors to decide the company’s future.

  • Jessica Yun and Emma Koehn
David Bortolussi A2

Chinese parents love A2 Milk’s infant formula. Do investors love it too?

The $4.3 billion milk and infant formula giant has engineered a commendable turnaround since COVID-19 – but are investors pleased?

  • Jessica Yun
A2 Milk has grown its China business in the first half of the 2023 financial year.

China marketing blitz pays dividends for A2 Milk

The infant formula maker has managed to ride out the harsh zero-COVID lockdowns imposed on its most lucrative market, but investors are not impressed.

  • Jessica Yun
A2 Milk chairman David Hearn will step down after serving on the company’s board for nine years.

A2 Milk appoints New Zealand dealmaker as new chair

Shares in the dairy and baby formula company dipped lower after A2 Milk announced changes to its board and outlook.

  • Jessica Yun
A2 Milk has finally gained US FDA approval to sell products to the US under the temporary enforcement discretion.

A2 Milk finds a way into US but sober about short-term gains

Dairy giant A2 Milk has been given the green light to export its infant formula to the US, more than five months after its smaller rival Bubs Australia was given approval.

  • Jessica Yun
Advertisement
A2 Milk has received approval for its Chinese-label baby formula supplier to continue making product until late February 2023.

Relief for A2 Milk as Chinese regulatory path untangles

A2 Milk’s shares have jumped after its Chinese-label baby formula producer received approval to continue manufacturing product until late February.

  • Jessica Yun
A2 Milk is hoping the US FDA will approve its bid to supply the US market with product to help ease an infant formula shortage.

‘Turning a corner’: A2 Milk retargets Chinese daigous amid $134m share buyback

Milk and infant formula maker A2 Milk is returning its focus back to daigou channels after it was forced by the pandemic to pivot and diversify.

  • Jessica Yun
The a2 Milk company’s profits have plummeted by more than half, but has outlined an optimistic outlook.

A2 Milk’s baby formula foray into US frustrated by FDA delay

A2 Milk has had its approval to import baby formula to the US deferred as it seeks to chase smaller Australian competitors in the market.

  • Angus Dalton
Joie Biden

Milk run: Biden sends more planes to pick up Bubs Australia infant formula

Bubs Australia is preparing to send 180,000 tins of infant formula to the US. Meanwhile, its much larger rival A2 Milk is still waiting for US FDA approval.

  • Jessica Yun

Original URL: https://www.watoday.com.au/topic/a2m-1iv